Journal of Hepatocellular Carcinoma | Volume 11

Plummer R, Greystoke A, Naylor G, Sarker D, Anam ANMK, Prenen H, Teuwen LA, Van Cutsem E, Dekervel J, Haugk B, Ness T, Bhoi S, Jensen M, Morris T, Baumann P, Sjögren N, Tunblad K, Wallberg H, Öberg F, Evans TRJ

Journal of Hepatocellular Carcinoma 2024, 11:2033-2047

Published Date: 24 October 2024

Original Research

Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis

Xu XY, Wang Z, Liu CY, Wu HD, Hu ZX, Lin YY, Zhang S, Shen J, Zhong BY, Zhu XL

Journal of Hepatocellular Carcinoma 2024, 11:2019-2032

Published Date: 22 October 2024

Original Research

Transarterial Chemoembolization Combined with Microwave Ablation in Elderly Patients with Recurrent Medium or Large Hepatocellular Carcinoma

Zhang C, Qin Y, Song Y, Liu Y, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:2005-2017

Published Date: 22 October 2024

Original Research

Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study

Shen X, Zhang JX, Liu J, Liu S, Shi HB, Cheng Y, Zhang QQ, Yin GW, Zu QQ

Journal of Hepatocellular Carcinoma 2024, 11:1993-2003

Published Date: 21 October 2024

Original Research

Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin

Lu SY, Sun HY, Zhou Y, Luo X, Liu S, Zhou WZ, Shi HB, Yang W, Tian W

Journal of Hepatocellular Carcinoma 2024, 11:1979-1992

Published Date: 22 October 2024

Original Research

Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy(HAIC) Combined with PD-1 Inhibitors for Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Multicenter Propensity Score Matching Analysis

Zhang F, Zhong S, Wei Q, Zhang H, Hu H, Zeng B, Zheng X

Journal of Hepatocellular Carcinoma 2024, 11:1961-1978

Published Date: 16 October 2024

Original Research

Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2

Wan W, Pan Y, Pang J, Bai X, Li L, Kang T, Chen J, Wen R, Wen D, Yang H, He Y

Journal of Hepatocellular Carcinoma 2024, 11:1945-1959

Published Date: 14 October 2024

Original Research

Tumor Growth Pattern and Intra- and Peritumoral Radiomics Combined for Prediction of Initial TACE Outcome in Patients with Primary Hepatocellular Carcinoma

Li J, Zhou M, Tong Y, Chen H, Su R, Tao Y, Zhang G, Sun Z

Journal of Hepatocellular Carcinoma 2024, 11:1927-1944

Published Date: 9 October 2024

Original Research

A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma

Tang X, Xue J, Zhang J, Zhou J

Journal of Hepatocellular Carcinoma 2024, 11:1907-1926

Published Date: 5 October 2024

Original Research

Gut Microbiome and Hepatic Transcriptomic Determinants of HCC Development in Mice with Metabolic Dysfunction-Associated Steatohepatitis

Dolapchiev LI, Gonzales KA, Cruz LR, Gagea M, Stevenson HL, Kwan SY, Beretta L

Journal of Hepatocellular Carcinoma 2024, 11:1891-1905

Published Date: 3 October 2024

Original Research

Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma – An Observational Study from Taiwan

Lin CH, Kuo YC, Kuo HC, Wang CT, Lin SM, Lee ACW, Yu MC, Lee WC, Chen CCE, Hsieh JCH

Journal of Hepatocellular Carcinoma 2024, 11:1875-1890

Published Date: 2 October 2024

Original Research

Multicenter Integration of MR Radiomics, Deep Learning, and Clinical Indicators for Predicting Hepatocellular Carcinoma Recurrence After Thermal Ablation

Wang Y, Zhang Y, Xiao J, Geng X, Han L, Luo J

Journal of Hepatocellular Carcinoma 2024, 11:1861-1874

Published Date: 2 October 2024

Original Research

Comprehensive Analysis of Angiogenesis and Ferroptosis Genes for Predicting the Survival Outcome and Immunotherapy Response of Hepatocellular Carcinoma

Wang P, Kong G

Journal of Hepatocellular Carcinoma 2024, 11:1845-1859

Published Date: 29 September 2024

Original Research

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study

Han R, Gan L, Sun L, Lang M, Tian X, Zhu K, Chen L, Li G, Song T

Journal of Hepatocellular Carcinoma 2024, 11:1835-1844

Published Date: 28 September 2024

Original Research

The Role of Lactate Dehydrogenase in Exploring the Immune Evasion in HCC Patients Who Underwent TACE: Implications for Clinical Application

Xie Y, Sun X, Xie F, Jian W, Wang Q, Ma X, Li C, Zhang K

Journal of Hepatocellular Carcinoma 2024, 11:1823-1833

Published Date: 29 September 2024

Review

Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases

Du F, Xie Y, Wu S, Ji M, Dong B, Zhu C

Journal of Hepatocellular Carcinoma 2024, 11:1801-1821

Published Date: 25 September 2024

Original Research

The Enhanced Role of Eosinophils in Radiomics-Based Diagnosis of Microvascular Invasion and Its Association with the Immune Microenvironment in Hepatocellular Carcinoma

Liu D, Wu J, Wang H, Dong H, Chen L, Jia N

Journal of Hepatocellular Carcinoma 2024, 11:1789-1800

Published Date: 25 September 2024

Original Research

Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study

Lin ZT, Wei SM, Wu JY, Zhang ZB, Wang SJ, Zhou JY, Luo MC, Zeng ZX, Ou XY, Fu YK, Li H, Liu DY, Wu JY, Yan ML

Journal of Hepatocellular Carcinoma 2024, 11:1777-1787

Published Date: 24 September 2024

Original Research

ZDHHC20 Activates AKT Signaling Pathway to Promote Cell Proliferation in Hepatocellular Carcinoma

Huang X, Wang M, Zhang D, Meng J, Liu P

Journal of Hepatocellular Carcinoma 2024, 11:1763-1775

Published Date: 18 September 2024

Original Research

Dendritic Cell-Related Gene Signatures in Hepatocellular Carcinoma: An Analysis for Prognosis and Therapy Efficacy Evaluation

Huang H, Peng S, Wei Y, Lan C, Qin W, Liao X, Yang CK, Zhu G, Zhou X, Peng T

Journal of Hepatocellular Carcinoma 2024, 11:1743-1761

Published Date: 17 September 2024

Letter

Predicting Treatment Response and Prognosis in Patients with Hepatocellular Carcinoma after Interventional Therapy [Letter]

Li H, Shen X, Wu J

Journal of Hepatocellular Carcinoma 2024, 11:1741-1742

Published Date: 17 September 2024

Original Research

Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study

Li R, Wang X, Li H, Wang M, Wang J, Wang W, Zhou Q

Journal of Hepatocellular Carcinoma 2024, 11:1727-1740

Published Date: 9 September 2024

Original Research

Effect of Low-Dose Aspirin Use After Thermal Ablation in Patients with Hepatocellular Carcinoma: A Retrospective Study

Chen S, Duan Y, Zhang Y, Cheng L, Cai L, Hou X, Wang X, Li W

Journal of Hepatocellular Carcinoma 2024, 11:1713-1725

Published Date: 7 September 2024

Original Research

Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma

Powell H, Coarfa C, Elisa Ruiz-Echartea, Grimm SL, Najjar O, Yu B, Olivares L, Scheurer ME, Ballantyne C, Alsarraj A, Emad Mohamed Salem, Thrift AP, El Serag HB, Kaochar S

Journal of Hepatocellular Carcinoma 2024, 11:1699-1712

Published Date: 7 September 2024

Original Research

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts

Xia WL, Zhao XH, Guo Y, Hu HT, Li HL

Journal of Hepatocellular Carcinoma 2024, 11:1689-1697

Published Date: 2 September 2024

Original Research

A Machine Learning Model Based on Counterfactual Theory for Treatment Decision of Hepatocellular Carcinoma Patients

Wei X, Wang F, Liu Y, Li Z, Xue Z, Tang M, Chen X

Journal of Hepatocellular Carcinoma 2024, 11:1675-1687

Published Date: 30 August 2024

Original Research

Exploring the MRI and Clinical Features of P53-Mutated Hepatocellular Carcinoma

Weng J, Xiao Y, Liu J, Liu X, He Y, Wu F, Ni X, Yang C

Journal of Hepatocellular Carcinoma 2024, 11:1653-1674

Published Date: 29 August 2024

Original Research

The Role of Timing of Progression and Early Salvage Surgery in Unresectable Hepatocellular Carcinoma Treated with TACE Plus TKIs and PD‑1 Inhibitors

Li X, Tang Z, Pang Q, Wang X, Bai T, Chen J, Wei M, Wei T, Li L, Wu F

Journal of Hepatocellular Carcinoma 2024, 11:1641-1652

Published Date: 24 August 2024

Original Research

AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism

Chen T, Xiang L, Zhang W, Xia Z, Chen W

Journal of Hepatocellular Carcinoma 2024, 11:1623-1639

Published Date: 24 August 2024

Original Research

Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Jiang J, Zhang H, Lai J, Zhang S, Ou Y, Fu Y, Zhang L

Journal of Hepatocellular Carcinoma 2024, 11:1607-1622

Published Date: 24 August 2024

Original Research

Optimising Surveillance in Hepatocellular Carcinoma: Patient-Defined Obstacles and Solutions

Qurashi M, von Wagner C, Sharma R

Journal of Hepatocellular Carcinoma 2024, 11:1597-1605

Published Date: 23 August 2024

Original Research

Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis

Hou G, Zhang F, Feng X, Chen Y, Zhang J, Wang H

Journal of Hepatocellular Carcinoma 2024, 11:1581-1595

Published Date: 20 August 2024

Original Research

An Oxidative Stress-Related Prognostic Signature Predicts Treatment Response and Outcomes for Hepatocellular Carcinoma After Transarterial Chemoembolization

Ma H, Yu T, Li ZC, Zhang L, Chen RX, Ren ZG

Journal of Hepatocellular Carcinoma 2024, 11:1569-1580

Published Date: 13 August 2024

Original Research

Clinical Therapy: HAIC Combined with Tyrosine Kinase Inhibitors and Programmed Cell Death Protein-1 Inhibitors versus HAIC Alone for Unresectable Hepatocellular Carcinoma

Liu B, Shen L, Liu W, Zhang Z, Lei J, Li Z, Tan Q, Huang H, Wang X, Fan W

Journal of Hepatocellular Carcinoma 2024, 11:1557-1567

Published Date: 12 August 2024

Original Research

Genetic Variants in p53 Pathway Genes Affect Survival of Patients with HBV-Related Hepatocellular Carcinoma

Qin L, Qiu M, Tang J, Liu S, Lin Q, Huang Q, Wei X, Wen Q, Chen P, Zhou Z, Cao J, Liang X, Guo Q, Nong C, Gong Y, Wei Y, Jiang Y, Yu H, Liu Y

Journal of Hepatocellular Carcinoma 2024, 11:1541-1555

Published Date: 12 August 2024

Original Research

Endoplasmic Reticulum Membrane Protein Complex Regulates Cancer Stem Cells and is Associated with Sorafenib Resistance in Hepatocellular Carcinoma

Liu YJ, Li JX, Li JP, Hu YD, Ma ZB, Huang W, Liu SL, Zou X

Journal of Hepatocellular Carcinoma 2024, 11:1519-1539

Published Date: 9 August 2024

Original Research

Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC

Zhang Y, Lei J, Ma H, Zuo S

Journal of Hepatocellular Carcinoma 2024, 11:1507-1517

Published Date: 8 August 2024

Original Research

Dynamic Changes of Neutrophil-to-Lymphocyte Ratio on Predicting Response of Immune Checkpoint Inhibitors Plus Targeted Therapies for Unresectable Hepatocellular Carcinoma

Yang J, Zhang Y, Chen Y, Yang Y, Deng Y

Journal of Hepatocellular Carcinoma 2024, 11:1495-1505

Published Date: 5 August 2024

Original Research

Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi

Li Z, Zhai Y, Wu F, Cao D, Ye F, Song Y, Wang S, Liu Y, Song Y, Tang Y, Jing H, Fang H, Qi S, Lu N, Li YX, Wu J, Chen B

Journal of Hepatocellular Carcinoma 2024, 11:1481-1493

Published Date: 5 August 2024

Original Research

Additional Hepatic Arterial Infusion Chemotherapy to Sorafenib Was Cost-Effective for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis

Chen QF, Jiang XY, Hu Y, Chen S, Yi JZ, Zhong SX, Wang JL, Lyu N, Zhao M

Journal of Hepatocellular Carcinoma 2024, 11:1473-1479

Published Date: 30 July 2024

Original Research

Comparisons of Percutaneous Ablation, Open or Laparoscopic Liver Resection for Barcelona Clinic Liver Cancer Stage 0-A Hepatocellular Carcinoma: A Concurrent Generalized Propensity Score Analysis

Chen ZH, Zhou Q, Chen ZB, Xie WX, Song ZM, Lin SR, Wang W, Shen SL, Kuang M

Journal of Hepatocellular Carcinoma 2024, 11:1459-1472

Published Date: 25 July 2024

Original Research

MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy

Kuang F, Gao Y, Zhou Q, Lu C, Lin Q, Al Mamun A, Pan J, Shi S, Tu C, Shao C

Journal of Hepatocellular Carcinoma 2024, 11:1445-1457

Published Date: 18 July 2024

Perspectives

Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community

Li D, Cheng S, Wilson Woods A, Luong A, Schiltz S, Tan R, Chi ZH

Journal of Hepatocellular Carcinoma 2024, 11:1439-1444

Published Date: 18 July 2024

Review

Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence

Li Y, Fan N, He X, Zhu J, Zhang J, Lu L

Journal of Hepatocellular Carcinoma 2024, 11:1429-1438

Published Date: 17 July 2024

Original Research

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study

Liu G, Zhu D, He Q, Zhou C, He L, Li Z, Jiang Z, Huang M, Chang B, Wu C

Journal of Hepatocellular Carcinoma 2024, 11:1415-1428

Published Date: 12 July 2024

Original Research

A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with DEB-TACE

Jiang B, Lu D, Dai J, Li K, Du Q, Xie B, Xie J, Zhu X, Xie X

Journal of Hepatocellular Carcinoma 2024, 11:1403-1414

Published Date: 10 July 2024

Original Research

Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study

Li YK, Wu S, Wu YS, Zhang WH, Wang Y, Li YH, Kang Q, Huang SQ, Zheng K, Jiang GM, Wang QB, Liang YB, Li J, Lakang Y, Yang C, Li J, Wang JP, Kui X, Ke Y

Journal of Hepatocellular Carcinoma 2024, 11:1389-1402

Published Date: 9 July 2024

Original Research

Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model

Xiong Y, Qiao W, Mei T, Li K, Jin R, Zhang Y

Journal of Hepatocellular Carcinoma 2024, 11:1375-1388

Published Date: 8 July 2024

Original Research

CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis

Liu WF, Jiang QY, Qi ZR, Zhang F, Tang WQ, Wang HQ, Dong L

Journal of Hepatocellular Carcinoma 2024, 11:1357-1373

Published Date: 9 July 2024

Original Research

New HCC Subtypes Based on CD8 Tex-Related lncRNA Signature Could Predict Prognosis, Immunological and Drug Sensitivity Characteristics of Hepatocellular Carcinoma

Ge J, Tao M, Zhang G, Cai J, Li D, Tao L

Journal of Hepatocellular Carcinoma 2024, 11:1331-1355

Published Date: 5 July 2024

Original Research

Utility of Machine Learning in the Prediction of Post-Hepatectomy Liver Failure in Liver Cancer

Tashiro H, Onoe T, Tanimine N, Tazuma S, Shibata Y, Sudo T, Sada H, Shimada N, Tazawa H, Suzuki T, Shimizu Y

Journal of Hepatocellular Carcinoma 2024, 11:1323-1330

Published Date: 5 July 2024

Original Research

The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma

Wang N, Xu Y, Yang G, Chen H, Wang X, Fu J, Li L, Pan X

Journal of Hepatocellular Carcinoma 2024, 11:1311-1321

Published Date: 4 July 2024

Original Research

IL-6 Released from Hepatic Stellate Cells Promotes Glycolysis and Migration of HCC Through the JAK1/vWF/TGFB1 Axis

Zhu Y, Gu J, Lu Y, Tao Q, Cao X, Zhu Y, Yang MQ, Liang X

Journal of Hepatocellular Carcinoma 2024, 11:1295-1310

Published Date: 5 July 2024

Original Research

Decision-Tree Models Indicative of Microvascular Invasion on MRI Predict Survival in Patients with Hepatocellular Carcinoma Following Tumor Ablation

Schmidt R, Hamm CA, Rueger C, Xu H, He Y, Gottwald LA, Gebauer B, Savic LJ

Journal of Hepatocellular Carcinoma 2024, 11:1279-1293

Published Date: 3 July 2024

Review

Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy

Lv X, Lan G, Zhu L, Guo Q

Journal of Hepatocellular Carcinoma 2024, 11:1265-1278

Published Date: 2 July 2024

Original Research

Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

Xiao Y, Chen W, Deng W, Zhu G, Xie J, Luo L, Lin L, Tao J, Hu Z, Shan R

Journal of Hepatocellular Carcinoma 2024, 11:1251-1263

Published Date: 2 July 2024

Original Research

Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma

Kim YR, Chung SW, Kim MJ, Choi WM, Choi J, Lee D, Lee HC, Shim JH

Journal of Hepatocellular Carcinoma 2024, 11:1235-1249

Published Date: 1 July 2024

Original Research

The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma

Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y

Journal of Hepatocellular Carcinoma 2024, 11:1221-1233

Published Date: 27 June 2024

Original Research

Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study

Li J, Li Y, Song J, Zhao L

Journal of Hepatocellular Carcinoma 2024, 11:1207-1219

Published Date: 27 June 2024

Original Research

The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy

Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q

Journal of Hepatocellular Carcinoma 2024, 11:1193-1206

Published Date: 24 June 2024

Original Research

Radiomics-Based Prediction of Microvascular Invasion Grade in Nodular Hepatocellular Carcinoma Using Contrast-Enhanced Magnetic Resonance Imaging

Zhang Z, Jia XF, Chen XY, Chen YH, Pan KH

Journal of Hepatocellular Carcinoma 2024, 11:1185-1192

Published Date: 21 June 2024

Review

GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications

Du YN, Zhao JW

Journal of Hepatocellular Carcinoma 2024, 11:1171-1183

Published Date: 19 June 2024

Original Research

PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study

Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C

Journal of Hepatocellular Carcinoma 2024, 11:1157-1170

Published Date: 18 June 2024

Review

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma

Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y

Journal of Hepatocellular Carcinoma 2024, 11:1143-1156

Published Date: 17 June 2024

Original Research

Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study

Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S, Cao Y, Zhu P

Journal of Hepatocellular Carcinoma 2024, 11:1127-1141

Published Date: 14 June 2024

Original Research

Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments

Qiao W, Xiong Y, Li K, Jin R, Zhang Y

Journal of Hepatocellular Carcinoma 2024, 11:1113-1125

Published Date: 13 June 2024

Original Research

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W

Journal of Hepatocellular Carcinoma 2024, 11:1095-1112

Published Date: 13 June 2024

Original Research

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J

Journal of Hepatocellular Carcinoma 2024, 11:1079-1093

Published Date: 12 June 2024

Original Research

Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia

Hong W, Wang Z, Yao W, Zhang X, Zhang L, Liang B

Journal of Hepatocellular Carcinoma 2024, 11:1065-1078

Published Date: 11 June 2024

Original Research

Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

Shi W, Yan H, Liu X, Yu L, Xie Y, Wu Y, Liang Y, Yang Z

Journal of Hepatocellular Carcinoma 2024, 11:1049-1063

Published Date: 7 June 2024

Original Research

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma

Xiao S, Lu L, Lin Z, Ye X, Su S, Zhang C, You Y, Li W, Huang X, Wu W, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:1031-1048

Published Date: 6 June 2024

Original Research

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2024, 11:1015-1029

Published Date: 5 June 2024

Case report

Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report

Zhu X, Dong S, Tang J, Xie R, Wu H, Guan J, Hu S

Journal of Hepatocellular Carcinoma 2024, 11:1005-1013

Published Date: 4 June 2024

Rapid Communication

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M

Journal of Hepatocellular Carcinoma 2024, 11:997-1004

Published Date: 31 May 2024

Review

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma

Palaz F, Ozsoz M, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2024, 11:975-995

Published Date: 30 May 2024

Expert Opinion

A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA

Journal of Hepatocellular Carcinoma 2024, 11:953-974

Published Date: 29 May 2024

Original Research

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI

Zhang J, Li Y, Xia J, Pan X, Lu L, Fu J, Jia N

Journal of Hepatocellular Carcinoma 2024, 11:941-952

Published Date: 25 May 2024

Original Research

Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis

Dai MG, Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B

Journal of Hepatocellular Carcinoma 2024, 11:927-939

Published Date: 23 May 2024

Original Research

A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1

He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J

Journal of Hepatocellular Carcinoma 2024, 11:913-925

Published Date: 22 May 2024

Original Research

A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy

Tang X, Wang Q, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:901-911

Published Date: 17 May 2024

Original Research

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma

Peng L, Xu S, Xu JL

Journal of Hepatocellular Carcinoma 2024, 11:879-900

Published Date: 16 May 2024

Original Research

Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes

Chen H, Li J, Cao D, Tang H

Journal of Hepatocellular Carcinoma 2024, 11:857-878

Published Date: 11 May 2024

Original Research

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)

Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S

Journal of Hepatocellular Carcinoma 2024, 11:839-855

Published Date: 9 May 2024

Original Research

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration

Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D

Journal of Hepatocellular Carcinoma 2024, 11:813-838

Published Date: 8 May 2024

Original Research

Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion

Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ

Journal of Hepatocellular Carcinoma 2024, 11:801-812

Published Date: 8 May 2024

Original Research

CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ

Journal of Hepatocellular Carcinoma 2024, 11:787-800

Published Date: 8 May 2024

Original Research

A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors

Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S

Journal of Hepatocellular Carcinoma 2024, 11:775-786

Published Date: 26 April 2024

Original Research

Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study

Hu Z, Zhou H

Journal of Hepatocellular Carcinoma 2024, 11:767-774

Published Date: 24 April 2024

Original Research

A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation

Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2024, 11:747-766

Published Date: 23 April 2024

Original Research

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis

Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y

Journal of Hepatocellular Carcinoma 2024, 11:737-746

Published Date: 18 April 2024

Original Research

Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study

Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B

Journal of Hepatocellular Carcinoma 2024, 11:721-735

Published Date: 8 April 2024

Review

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I

Journal of Hepatocellular Carcinoma 2024, 11:707-719

Published Date: 6 April 2024

Original Research

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy

Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z

Journal of Hepatocellular Carcinoma 2024, 11:693-705

Published Date: 4 April 2024

Original Research

Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery

Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J

Journal of Hepatocellular Carcinoma 2024, 11:679-691

Published Date: 3 April 2024

Original Research

Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis

Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R

Journal of Hepatocellular Carcinoma 2024, 11:665-678

Published Date: 4 April 2024

Original Research

High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization

Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D

Journal of Hepatocellular Carcinoma 2024, 11:651-663

Published Date: 27 March 2024

Review

The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

Chen W, Hu Z, Li G, Zhang L, Li T

Journal of Hepatocellular Carcinoma 2024, 11:629-649

Published Date: 27 March 2024

Original Research

The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients

Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K

Journal of Hepatocellular Carcinoma 2024, 11:619-628

Published Date: 25 March 2024

Original Research

Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions

Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H

Journal of Hepatocellular Carcinoma 2024, 11:607-618

Published Date: 23 March 2024

Original Research

Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK

Journal of Hepatocellular Carcinoma 2024, 11:595-606

Published Date: 20 March 2024

Review

Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma

Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G

Journal of Hepatocellular Carcinoma 2024, 11:581-594

Published Date: 19 March 2024

Original Research

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro

Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF

Journal of Hepatocellular Carcinoma 2024, 11:565-580

Published Date: 19 March 2024

Corrigendum

Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X

Journal of Hepatocellular Carcinoma 2024, 11:563-564

Published Date: 14 March 2024

Original Research

LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J

Journal of Hepatocellular Carcinoma 2024, 11:543-562

Published Date: 11 March 2024

Original Research

A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma

Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B

Journal of Hepatocellular Carcinoma 2024, 11:525-542

Published Date: 12 March 2024

Original Research

Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy

Qiao W, Sheng S, Li J, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:509-523

Published Date: 7 March 2024

Original Research

Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation

Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J

Journal of Hepatocellular Carcinoma 2024, 11:489-508

Published Date: 6 March 2024

Original Research

Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma

Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:477-488

Published Date: 4 March 2024

Original Research

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy

Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2024, 11:463-475

Published Date: 4 March 2024

Original Research

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Chamseddine S, LaPelusa M, Xiao L, Mohamed YI, Lee SS, Hu ZI, Hatia RI, Hassan M, Yao JC, Duda DG, Datar S, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2024, 11:455-461

Published Date: 4 March 2024

Original Research

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma

Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK

Journal of Hepatocellular Carcinoma 2024, 11:443-454

Published Date: 5 March 2024

Original Research

Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter Study

Wang F, Yan CY, Qin Y, Wang ZM, Liu D, He Y, Yang M, Wen L, Zhang D

Journal of Hepatocellular Carcinoma 2024, 11:427-442

Published Date: 29 February 2024

Original Research

Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers

Huang C, Xiao X, Tong L, Gao Z, Ji J, Zhou L, Li Y, Liu L, Feng H, Fang M, Gao C

Journal of Hepatocellular Carcinoma 2024, 11:411-425

Published Date: 27 February 2024

Original Research

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study

Cai H, Chen S, Wu Z, Wang F, Tang S, Chen L, Guo W

Journal of Hepatocellular Carcinoma 2024, 11:399-409

Published Date: 26 February 2024

Original Research

A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization

Sun Z, Li X, Liang H, Shi Z, Ren H

Journal of Hepatocellular Carcinoma 2024, 11:385-397

Published Date: 26 February 2024

Original Research

Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment

Liang Y, Zhong D, Yang Q, Tang Y, Qin Y, Su Y, Huang X, Shang J

Journal of Hepatocellular Carcinoma 2024, 11:373-383

Published Date: 22 February 2024

Review

Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?

Himmelsbach V, Koch C, Trojan J, Finkelmeier F

Journal of Hepatocellular Carcinoma 2024, 11:363-372

Published Date: 19 February 2024

Expert Opinion

Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia

Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, Alsharm A, Mahrous M, Al Zanbagi A, Hassanain M, Bazarbashi S

Journal of Hepatocellular Carcinoma 2024, 11:349-362

Published Date: 16 February 2024

Response to Letter

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Response to Letter]

Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y

Journal of Hepatocellular Carcinoma 2024, 11:347-348

Published Date: 14 February 2024

Review

Lipid Metabolism as a Potential Target of Liver Cancer

Wu K, Lin F

Journal of Hepatocellular Carcinoma 2024, 11:327-346

Published Date: 14 February 2024

Original Research

The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions

Luo QQ, Li QN, Cai D, Jiang S, Liu SS, Liu MS, Lv C, Wang JK, Zhang KH, Wang T

Journal of Hepatocellular Carcinoma 2024, 11:317-325

Published Date: 8 February 2024

Original Research

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy

Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J

Journal of Hepatocellular Carcinoma 2024, 11:305-316

Published Date: 8 February 2024

Original Research

RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer

Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, Yin HH, Lu CM, Wen DY, He Y, Yang H

Journal of Hepatocellular Carcinoma 2024, 11:285-304

Published Date: 5 February 2024

Original Research

Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation

Qiao W, Li J, Wang Q, Jin R, Zhang H

Journal of Hepatocellular Carcinoma 2024, 11:271-284

Published Date: 3 February 2024

Original Research

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y

Journal of Hepatocellular Carcinoma 2024, 11:257-269

Published Date: 3 February 2024

Original Research

Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma

Qiu X, Dong L, Wang K, Zhong X, Xu H, Xu S, Guo H, Wei X, Chen W, Xu X

Journal of Hepatocellular Carcinoma 2024, 11:241-255

Published Date: 2 February 2024

Original Research

Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma

Zhang C, Tao Y, Yang R, Wang Y, Yu Y, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:229-240

Published Date: 26 January 2024

Original Research

A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy

Yang H, Lu L, Guo W, Gong B, Wang X, Chen Y, Chen X

Journal of Hepatocellular Carcinoma 2024, 11:219-228

Published Date: 25 January 2024

Original Research

Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors

Shen J, Wang X, Yang G, Li L, Fu J, Xu W, Zhang Q, Pan X

Journal of Hepatocellular Carcinoma 2024, 11:207-217

Published Date: 24 January 2024

Original Research

A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study

Wang H, Chen JJ, Yin SY, Sheng X, Wang HX, Lau WY, Dong H, Cong WM

Journal of Hepatocellular Carcinoma 2024, 11:191-206

Published Date: 24 January 2024

Original Research

Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X

Journal of Hepatocellular Carcinoma 2024, 11:175-189

Published Date: 24 January 2024

Letter

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe [Letter]

Chen C, Cai J, Li L

Journal of Hepatocellular Carcinoma 2024, 11:173-174

Published Date: 23 January 2024

Review

The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma

Mai Y, Meng L, Deng G, Qin Y

Journal of Hepatocellular Carcinoma 2024, 11:159-171

Published Date: 19 January 2024

Original Research

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease

Miao T, Lou X, Dong S, Zhang X, Guan W, Zhang Y, Li L, Yuan X, Ma D, Nan Y

Journal of Hepatocellular Carcinoma 2024, 11:145-157

Published Date: 18 January 2024

Original Research

Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma

Wang Z, Kong L, Zhang R, Yang X, Cao Z, Xu T, Zhang H, Dou Y

Journal of Hepatocellular Carcinoma 2024, 11:131-143

Published Date: 16 January 2024

Review

Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma

Huang X, Wang M, Zhang D, Zhang C, Liu P

Journal of Hepatocellular Carcinoma 2024, 11:113-129

Published Date: 16 January 2024

Original Research

The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels

Cong T, Yang C, Cao Q, Ren J, Luo Y, Yuan P, Zheng B, Liu Y, Yang H, Kang W, Ou A, Li X

Journal of Hepatocellular Carcinoma 2024, 11:95-111

Published Date: 17 January 2024

Original Research

First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison

Mahn R, Glüer OA, Sadeghlar F, Möhring C, Zhou T, Anhalt T, Monin MB, Kania A, Glowka TR, Feldmann G, Brossart P, Kalff JC, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA

Journal of Hepatocellular Carcinoma 2024, 11:81-94

Published Date: 13 January 2024

Original Research